At GEA we believe that continuous processing improves the quality of pharmaceutical end products: by focusing on quality during the whole product life-cycle, not just “tested in” quality; and by understanding the capability of your processes, managing sources of variability and decreasing any associated risks.
Our solution for continuous tableting lines is ConsiGma®, a 6 sigma-inspired manufacturing platform, incorporating different technologies to produce oral solid dosage forms in a continuous, cost-efficient way:
Affichage de 4 sur 6
The ConsiGma® CF20 test rig is a standalone module that allows you to characterize the feeding behavior of your products during the early stages of R&D.
An indispensable part of the ConsiGma 4.0 portfolio, the Conductor 4.0 control system architecture ensures smooth operation and communication between the different elements of a pharmaceutical continuous manufacturing line
A highly integrated solution for continuous linear blending and direct compression, the ConsiGma® DC-LB lines offer all the advantages of continuous manufacturing: supply chain agility, small footprint, controlled blending and compression and improved quality.
Designed to achieve optimal blending results, the ConsiGma® DB modules facilitate the testing of dosing and blending operations and can be integrated with any continuous up- or downstream process.
Quand vous développez des centrifugeuses, chaque goutte et chaque kilowatt-heure comptent. GEA fabriquant des centrifugeuses depuis plus de 130 ans, vous pourriez donc croire que nous ne nous y intéressons plus tant que cela...
En investissant dans les énergies renouvelables, GEA abaisse ses émissions de CO<sub>2</sub> à travers le monde.
Quand il s’agit d’améliorer la santé de la planète, GEA est aux manettes. Un de nos objectifs stratégiques qui met le développement durable au cœur est d’ouvrir une voie pour aider nos clients, qui opèrent dans de nombreux secteurs...